Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 90 | 0 | 0 | 0 | 0 |
| Gross Profit | 90 | N/A | N/A | N/A | N/A |
| Operating Expenses | 5,782 | 7,503 | 16,638 | 7,505 | 12,601 |
| Operating Income | -5,692 | -7,503 | -16,638 | -7,505 | -12,601 |
| Other Income | 561 | 625 | 700 | 853 | 1,033 |
| Pre-tax Income | -5,131 | -6,878 | -15,938 | -6,652 | -11,568 |
| Net Income Continuous | -5,131 | -6,878 | -15,938 | -6,652 | -11,568 |
| Net Income | $-5,131 | $-6,878 | $-15,938 | $-6,652 | $-11,568 |
| EPS Basic Total Ops | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 |
| EPS Basic Continuous Ops | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 |
| EPS Diluted Total Ops | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 |
| EPS Diluted Continuous Ops | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.22 | -0.51 | -0.21 | -0.37 |
| EBITDA(a) | $-5,486 | $-7,299 | $-16,433 | $-7,301 | $-12,399 |